SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-021333
Filing Date
2021-04-28
Accepted
2021-04-28 16:04:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A urgn-defa14a_20210426.htm DEFA14A 33376
2 GRAPHIC glbwc4br15il000001.jpg GRAPHIC 147672
3 GRAPHIC glbwc4br15il000002.jpg GRAPHIC 147268
  Complete submission text file 0001564590-21-021333.txt   440726
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38079 | Film No.: 21864183
SIC: 2834 Pharmaceutical Preparations